Pulmonary artery denervation - the suspense continues?

EuroIntervention 2023;19:623-624. DOI: 10.4244/EIJ-E-23-00033

Felix Mahfoud
Felix Mahfoud1, MD, MA; Felix Götzinger1, MD
1. Department of Internal Medicine III - Cardiology, Angiology, and Internal Intensive Care Medicine, Saarland University Hospital, Homburg, Germany
The 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) Guidelines for the management of pulmonary hypertension (PH) define PH as a mean pulmonary artery pressure (mPAP) of >20 mmHg at rest, as determined by an invasive measurement in the pulmonary arteries (PA)1. PH is a multifaceted disease and often an undetected cause of dyspnoea, fatigue, and loss of exercise capacity2. The prevalence of PH in the global population is about 1% and is continuously increasing3. According to the ESC/ERS and the World Health Organization (WHO), PH is classified and divided into 5 groups. PH Group 1 encompasses ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The quest to refine atrial fibrillation-related stroke risk stratification: could the answer lie in left atrial appendage angiography?

Latest news